Revolutionary HIV Prevention Drug Shows Near-Perfect Protection
The U.S. Food and Drug Administration made a groundbreaking announcement in June 2025, approving lenacapavir (Yeztugo) for use as a twice-yearly PrEP injection that provided nearly 100% protection in trials.…